Acute bilateral ECT in a depressed patient with a hip-aztreonam-spacer and subsequent maintenance ECT after prosthesis collocation

2014 ◽  
Vol 27 (2) ◽  
pp. 343-346 ◽  
Author(s):  
Verònica Gálvez ◽  
Aida de Arriba Arnau ◽  
Erika Martínez-Amorós ◽  
Carmina Ribes ◽  
Mikel Urretavizcaya ◽  
...  
Keyword(s):  
Major Depressive Disorder ◽  
Hip Fracture ◽  
Multidisciplinary Approach ◽  
Geriatric Patients ◽  
Case Reports ◽  
Geriatric Depression ◽  
Major Depressive ◽  
Maintenance Ect ◽  
Dsm Iv ◽  
Psychotic Features

ABSTRACTElectroconvulsive Therapy (ECT) has been demonstrated to be a safe and effective treatment for geriatric depression, although its application might be challenging when medical comorbidities exist. The present case reports a 78-year-old man diagnosed with recurrent unipolar major depressive disorder (MDD), who presented with a severe depressive episode with psychotic features (DSM IV). He successfully received a course of bitemporal (BT) ECT with a hip-aztreonam-spacer due to a hip fracture that occurred during hospitalization. This was followed by maintenance ECT (M-ECT) with a recent prosthesis collocation. This particular case illustrates the importance of a multidisciplinary approach in geriatric patients with somatic complications receiving ECT.

scholarly journals A Case Series: Adjunctive Treatment of Major Depressive Disorder in the Geriatric Population with the Methylphenidate Patch

2019 ◽  
Vol 2019 ◽  
pp. 1-3
Author(s):  
Kamal Patel ◽  
Ashley Collins ◽  
Suzanne Holroyd ◽  
Andre Benja Lamyaithong
Keyword(s):  
Major Depressive Disorder ◽  
Depressive Disorder ◽  
Elderly Patients ◽  
Initial Treatment ◽  
Geriatric Patients ◽  
Case Series ◽  
Adjunctive Treatment ◽  
Major Depressive ◽  
Geriatric Population ◽  
Psychotic Features

Major depressive disorder can affect anyone regardless of age. In geriatric populations depression is often overlooked and untreated, which subsequently may lead to serious consequences. Almost one third of elderly patients with depression fail to respond to initial treatment and require adjunctive treatment. Methylphenidate is one such option, which is seldom used in the geriatric population to treat depression despite reports of improvement in symptoms of mood within a brief period of time. Methylphenidate is also available in a patch formulation that can be used in patient’s nonadherent to the medication, which is reported to be an issue in as many as 75% of the geriatric population. Here we present three geriatric patients who were diagnosed with recurrent severe major depressive disorder without psychotic features. The three patients responded well with methylphenidate as adjunctive treatment to conventional antidepressants.

Korean medication algorithm for depressive disorder (II): Major depressive disorder without psychotic features

2008 ◽  
Vol 107 ◽  
pp. S90
Author(s):  
J.H. Seok ◽  
D.I. Jon ◽  
K.J. Min⁎ ◽  
W.M. Bahk ◽  
J.P. Hong ◽  
...  
Keyword(s):  
Major Depressive Disorder ◽  
Depressive Disorder ◽  
Major Depressive ◽  
Psychotic Features

Brief Report: Major Depressive Disorder with Psychotic Features in Williams Syndrome: A Case Series

2017 ◽  
Vol 48 (3) ◽  
pp. 947-952 ◽  
Author(s):  
Francisca Valdes ◽  
Christopher J. Keary ◽  
Jennifer E. Mullett ◽  
Michelle L. Palumbo ◽  
Jessica L. Waxler ◽  
...  
Keyword(s):  
Major Depressive Disorder ◽  
Depressive Disorder ◽  
Williams Syndrome ◽  
Case Series ◽  
Major Depressive ◽  
Psychotic Features

Twelve-month prevalence and disability of DSM-IV bipolar disorder in an Australian general population survey

2004 ◽  
Vol 34 (5) ◽  
pp. 777-785 ◽  
Author(s):  
P. B. MITCHELL ◽  
T. SLADE ◽  
G. ANDREWS
Keyword(s):  
Bipolar Disorder ◽  
Major Depressive Disorder ◽  
Depressive Disorder ◽  
National Survey ◽  
Large Scale ◽  
Well Being ◽  
Major Depressive ◽  
Co Morbidity ◽  
Dsm Iv ◽  
Days Out Of Role

Background. There have been few large-scale epidemiological studies which have examined the prevalence of bipolar disorder. The authors report 12-month prevalence data for DSM-IV bipolar disorder from the Australian National Survey of Mental Health and Well-Being.Method. The broad methodology of the Australian National Survey has been described previously. Ten thousand, six hundred and forty-one people participated. The 12-month prevalence of euphoric bipolar disorder (I and II) – similar to the euphoric-grandiose syndrome of Kessler and co-workers – was determined. Those so identified were compared with subjects with major depressive disorder and the rest of the sample, on rates of co-morbidity with anxiety and substance use disorders as well as demographic features and measures of disability and service utilization. Polychotomous logistic regression was used to study the relationship between the three samples and these dependent variables.Results. There was a 12-month prevalence of 0·5% for bipolar disorder. Compared with subjects with major depressive disorder, those with bipolar disorder were distinguished by a more equal gender ratio; a greater likelihood of being widowed, separated or divorced; higher rates of drug abuse or dependence; greater disability as measured by days out of role; increased rates of treatment with medicines; and higher lifetime rates of suicide attempts.Conclusions. This large national survey highlights the marked functional impairment caused by bipolar disorder, even when compared with major depressive disorder.

Prolactin secretion in response to haloperidol challenge in delusional (psychotic) and non-delusional depression

2000 ◽  
Vol 15 (8) ◽  
pp. 480-482 ◽  
Author(s):  
L Lykouras ◽  
M Markianos ◽  
J Hatzimanolis ◽  
P Oulis ◽  
G.N Christodoulou
Keyword(s):  
Major Depressive Episode ◽  
Prolactin Secretion ◽  
Psychotic Depression ◽  
Major Depressive ◽  
Time Effects ◽  
Delusional Depression ◽  
Neurotransmitter Activity ◽  
Patient Groups ◽  
Dsm Iv ◽  
Psychotic Features

Certain studies on measures related to central neurotransmitter activity have demonstrated that in delusional (psychotic) depression there is a dopaminergic dysregulation which distinguishes it from non-psychotic depression. A neuroendocrinologic method to check the degree of DA receptor responsivity is by measuring the prolactin responses to acute intramuscular administration of haloperidol. We studied this possibility by applying the haloperidol test in seven delusional and ten non-delusional depressed patients. All patients met DSM-IV criteria for a major depressive episode, single or recurrent, with or without psychotic features. After a three-week washout period, 5 mg of haloperidol were injected i.m. and blood samples were taken at 0, 30, 60, 90 and 120 minutes. In both trials, significant time effects were observed (elevated prolactin levels, F = 11.36, P = 0.000). However, the prolactin responses to haloperidol did not differ significantly between the two patient groups (F = 0.12, P = 0.97). These data do not show a difference in D2 receptor responsivity, at least at the hypothalamus-pituitary level, between psychotic and non-psychotic depression.

Major depressive disorder with psychotic features induced by interferon-α treatment for hepatitis C in a polydrug abuser

2005 ◽  
Vol 19 (1) ◽  
pp. 102-105 ◽  
Author(s):  
O. Ayhan Kalyoncu ◽  
Devran Tan ◽  
Hasan Mirsal ◽  
Ozkan Pektas ◽  
Mansur Beyazyurek
Keyword(s):  
Major Depressive Disorder ◽  
Hepatitis C ◽  
Depressive Disorder ◽  
Interferon Α ◽  
Major Depressive ◽  
Psychotic Features

scholarly journals Toward an Adaptation of Interpersonal Psychotherapy for Hispanic Patients With DSM-IV Major Depressive Disorder

2008 ◽  
Vol 70 (2) ◽  
pp. 214-222 ◽  
Author(s):  
John C. Markowitz ◽  
Sapana R. Patel ◽  
Ivan C. Balan ◽  
Michelle A. Bell ◽  
Carlos Blanco ◽  
...  
Keyword(s):  
Major Depressive Disorder ◽  
Depressive Disorder ◽  
Interpersonal Psychotherapy ◽  
Major Depressive ◽  
Hispanic Patients ◽  
Dsm Iv

Severity and Comorbidity Predict Episode Duration and Recurrence of DSM-IV Major Depressive Disorder

2004 ◽  
Vol 65 (6) ◽  
pp. 810-819 ◽  
Author(s):  
Tarja K. Melartin ◽  
Heikki J. Rytsälä ◽  
Ulla S. Leskelä ◽  
Paula S. Lestelä-Mielonen ◽  
T. Petteri Sokero ◽  
...  
Keyword(s):  
Major Depressive Disorder ◽  
Depressive Disorder ◽  
Major Depressive ◽  
Episode Duration ◽  
Dsm Iv

scholarly journals Lifetime prevalence and inter-cohort variation in DSM-IV disorders in metropolitan China

2006 ◽  
Vol 37 (1) ◽  
pp. 61-71 ◽  
Author(s):  
SING LEE ◽  
ADLEY TSANG ◽  
MING-YUAN ZHANG ◽  
YUE-QIN HUANG ◽  
YAN-LING HE ◽  
...  
Keyword(s):  
Major Depressive Disorder ◽  
Mental Disorders ◽  
Depressive Disorder ◽  
Age Of Onset ◽  
Lifetime Risk ◽  
Lifetime Prevalence ◽  
Major Depressive ◽  
Cross Sectional ◽  
Dsm Iv ◽  
Prospective Longitudinal

Background. This is the first study to examine variation across cohorts in lifetime risk of DSM-IV mental disorders in metropolitan China.Method. Face-to-face household interviews of 2633 adults in Beijing and 2568 adults in Shanghai were conducted from November 2001 to February 2002 using a multi-stage household probability sampling method. The Chinese World Mental Health (WMH) Survey Initiative version of the WHO Composite International Diagnostic Interview (WMH-CIDI) was used for assessment.Results. Lifetime prevalence of any disorder was 13·2%. Alcohol abuse (4·7%), major depressive disorder (3·5%), and specific phobia (2·6%) were the most common disorders. The median age of onset was later for mood (43 years) than anxiety (17 years) and substance use (25 years) disorders. Compared to observed lifetime prevalence, the projected lifetime risk as of age 75 years increased by 106% for major depressive disorder (7·2%), and was uniformly higher for all disorders. Relative odds of any lifetime disorder were 4·7 in the most recent cohorts (ages 18–34) compared to the eldest cohorts (ages [ges ]65).Conclusions. The findings of this cross-sectional study tally with the view that rapid socioeconomic changes may bring about increasing incidence of mental disorders in China. However, prospective longitudinal studies are needed to confirm if the increase is real. Because of the huge size of the Chinese population, any increase in projected lifetime risk of mental disorders represents an enormous increase in the number of affected individuals.

Sign in / Sign up

Export Citation Format

Share Document